期刊文献+

曲古抑菌素A联合多西他赛促进肺腺癌细胞的凋亡及其可能的分子机制

Trichostatin A combined with docetaxel promote apoptosis of lung adenocarcinoma cells and the possible molecular mechanisms
下载PDF
导出
摘要 目的:研究曲古抑菌素A(trichostatin A,TSA)联合多西他赛(docetaxel,Doc)对肺腺癌细胞A549凋亡的影响及其分子机制。方法:TSA单独或联合Doc处理A549细胞,MTT法检测A549细胞的增殖,光学显微镜下观察A549细胞的形态学变化,Hoechst 33258染色及流式细胞术检测A549细胞的凋亡,流式细胞术检测细胞周期的变化,Western blotting检测乙酰化-α-微管蛋白(acetyl-α-tubulin)、survivin蛋白的表达及caspase-3的活化。结果:10μg/ml Doc、250 nmol/L TSA单独或联合作用均能时间依赖性地抑制A549细胞的增殖,联合作用的抑制率显著高于Doc或TSA单独作用[(65.6±3.1)%vs(30.6±2.1)%、(23.3±1.9)%,P<0.05]。TSA、Doc单独或联合用药均可使A549细胞凋亡率增加,联合作用的凋亡率显著高于单独作用[(58±3.6)%vs(17±2.2)%、(14±1.6)%,P<0.05]。联合作用比单独作用使A549细胞更明显地阻滞于G2/M期[(32.4±3.1)%vs(23.5±2.3)%、(10.5±1.5)%,P<0.05]。TSA联合Doc可进一步增加acetyl-α-tubulin表达、减少sur-vivin蛋白的表达,并促进casapase-3的活化(均P<0.05)。结论:TSA联合Doc能够抑制A549细胞的增殖、促进细胞的凋亡,其机制可能与上调acetyl-α-tubulin的表达、抑制survivin的表达以及促进caspase-3活化有关。 Objective:To explore the effects of trichostatin A(TSA) and docetaxel(Doc) on apoptosis of lung adenocarcinoma A549 cells and the possible molecular mechanisms.Methods: A549 cells were treated with TSA alone or in combination with Doc,MTT assay was used to measure the proliferation of A549 cells;cell morphological changes were observed under light microscope;apoptosis was assessed using Hoechst 33258 staining and flow cytometry;cell cycle was analyzed by flow cytometry;the expression of acetyl-α-tubulin and survivin protein and activation of caspase-3 were detected by Western blotting.Results: 10 μg/ml Doc and 250 nmol/L TSA alone or in combination significantly inhibited the growth of A549 cells in a time-dependent manner,and the combined treatment induced even higher inhibitory rate([65.6±3.1]% vs [30.6±2.1]%,[23.3±1.9]%,P0.05).In addition,TSA or Doc alone or in combination increased the apoptosis rate of A549 cells,and the combined treatment also induced higher apoptosis rate([58±3.6]% vs [17±2.2]%,[14±1.6]%,P0.05).The cell cycle was more markedly arrested in G2/M phase in combination treatment group([32.4±3.1]% vs [23.5±2.3]%,[10.5±1.5]%,P0.05),TSA combined with Doc increased the expression of acetyl-α-tubulin,reduced the expression of survivin and promoted the activation of caspase-3(P0.05).Conclusion: TSA combined with Doc can inhibit proliferation and induce apoptosis of A549 cells,which is related to the up-regulation of acetyl-α-tubulin,down-regulation of survivin and increased activation of caspase-3.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第5期496-501,共6页 Chinese Journal of Cancer Biotherapy
基金 山东省卫生厅科研基金资助项目(No.32009) 山东省科技发展计划资助项目(No.2010G0020227)~~
关键词 曲古抑菌素A 多西他赛 肺癌 微管蛋白 生存素 trichostatin A docetaxel lung cancer tubulin survivin
  • 相关文献

参考文献21

  • 1Owonikoko TK, Ramalingam SS, Kanterewicz B, et al. Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells [J]. Int J Cancer, 2010, 126(3) : 743-755.
  • 2Giommarelli C, Znco V, Favini E, et al, The enhancement ofan- tiproliferative and proapoptotic activity of HDAC inhibitors by cur- cumin is mediated by Hsp90 inhibition [ J ]. Cell Mol Life Sci, 2010, 67(6) : 995-1004.
  • 3Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lyrnphoma [ J ]. Nat Med, 1997, 3(8) : 917-921.
  • 4Cecconi D, Donadelli M, Dalla PE, et al. Synergistic effect of tri- chostatin A and 5-aza-2-deoxycytidine on growth inhibition of pan- creatic endocrine tumour cell lines : A proteomic study [ J ]. Pro- teomics, 2009, 9(7) : 1952-1966.
  • 5Chakravarty G, Rider B, Mondal D. Cytoplasmic compartmental- ization of SOX9 abrogates the growth arrest response of breast canc- er cells that can be rescued by trichostatin A treatment [ J]. Canc- er Biol Ther, 2011, 11(1) : 71-83.
  • 6Chu CW, Hou F, Zhang J, et al. A novel acetylation of 15-tubulin by San modulates microtubule polymerization via down-regulating tubulin incorporation [ J ]. Mol Biol Cell, 2011, 22 (4) : 448- 456.
  • 7Blagosklonny MV, Robey R, Sackett DL, et al. Histone deacety- lase inhibitors all induce p21 but differentially cause tubulin acety- lation, mitotic arrest, and cytotoxicity [J]. Mol Cancer Ther, 2002, 1(11) : 937-941.
  • 8Dowdy SC, Jiang S, Zhou XC, et al. Histone deacetylase inhibi- tots and paclitaxel cause synergistic effects on apoptosis and micro- tubule stabilization in papillary serous endometrial cancer cells [ J]. Mol Cancer Ther, 2006, 5 ( 11 ) : 2767-2776.
  • 9Kamemura K, ho A, Shimazu T, et al. Effects of downregulated HDAC6 expression on the proliferation of lung cancer ceils [ J ]. Biochem Biophys Res Commun, 2008, 374( 1 ) : 84-89.
  • 10Jemal A, Siegel R, Ward E, et al. Cancer stasistics, 2009 [J]. CA Cancer J Clin, 2009, 59(4) : 225-249.

二级参考文献21

  • 1张旭辉,于晓妉,赵名,易欣,杜芝燕,徐元基.曲古菌素A诱导前列腺癌DU-145细胞有丝分裂的灾变[J].中国肿瘤生物治疗杂志,2007,14(3):206-211. 被引量:1
  • 2Favrot M, Coll JL, Louis N, et al. Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy[J]. Gene Ther, 1998, 5(6) : 728-739.
  • 3Zhang X, Yashiro M, Ohira M, et al. Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma[J]. Cancer Sci, 2006, 97 (9) : 938-944.
  • 4Law AY, Lai KP, Lui WC, et al. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation [ J]. Exp Cell Res, 2008, 314(16) :2975-2984.
  • 5Lee E J, Lee BB, Kim SJ, et al. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells[J]. Int J Oncol, 2008, 33(4) : 767-776.
  • 6Liao PC, Tan SK, Lieu CH, et al. Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis [ J ]. J Cell Biochem, 2008,104(4) : 1509-1523.
  • 7Kutuk O, Letai A. Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737 [J]. Cancer Res, 2008,68 (19) :7985-7994.
  • 8Zhang L, Dermawan K, Jin M, et al. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy [ J]. Clin Immunol, 2008, 129(2) :219-229.
  • 9Elit L, Hirte H. Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer [J].Curr Opin Obstet Gynecol, 2002 , 14 (1) :67-73.
  • 10Budillon A, Bruzzese F, Di Gennaro E, et al. Multiple-target drugs : inhibitors of heat shock protein 90 and of histone deacetylase[J]. Curr Drug Targets, 2005, 6(3) : 337-351.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部